{
    "nctId": "NCT04474951",
    "briefTitle": "Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies",
    "officialTitle": "Food Supplements to Control Signs and Symptoms Induced by Cancer Therapies",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Gynecologic Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Anemia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or Female \u2265 18 years\n* Karnofsky Performance Scale (KPS) \u2265 90%\n* Breast or Gynecological cancer\n* Informed consent signed before every procedure study specific, on day 1 of therapy cycle\n* Inclusion Criteria Arm 1: presence of grade 1 anemia as per CTCAE 4.0 criteria; patients on treatment with anti-CDK 4/6 or PARP Inhibitors or in adjuvant therapy with hormone therapy\n* Inclusion Criteria Arm 2: presence of fatigue of any grade; patients on treatment with Epirubicin and Cyclophosphamide or Carboplatin and Taxane\n* Inclusion Criteria Arm 3: presence of nausea of any grade, without vomiting; patients on treatment with Epirubicin and Cyclophosphamide or Carboplatin and Taxane\n\nExclusion Criteria:\n\n* Arm 1, 2 and 3: Previous intake of food supplements within 4 weeks from the enrollment\n* Arm 2: patients with evidence of anxiety or anxious-depressive syndrome; Clinical hypothyroidism not compensated by replacement therapy; Persistent insomnia\n* Arm 3: patients with evidence of anxiety or anxious-depressive syndrome",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}